These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26546030)

  • 21. R634W KIT Mutation in an Adult With Systemic Mastocytosis.
    Astle JM; Rose MG; Racke FK; Tormey CA; Siddon AJ
    Lab Med; 2017 Aug; 48(3):253-257. PubMed ID: 28520972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study.
    Meni C; Georgin-Lavialle S; Le Saché de Peufeilhoux L; Jais JP; Hadj-Rabia S; Bruneau J; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Bodemer C
    Br J Dermatol; 2018 Oct; 179(4):925-932. PubMed ID: 29787623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous mastocytosis in Singapore.
    Tay YK; Giam YC
    Singapore Med J; 1993 Oct; 34(5):425-9. PubMed ID: 8153691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current state of biology and diagnosis of clonal mast cell diseases in adults.
    Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
    Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations.
    Drabent P; Mitri R; Le Naour G; Hermine O; Rossignol J; Molina TJ; Barete S; Fraitag S
    Am J Dermatopathol; 2021 Jan; 43(1):35-41. PubMed ID: 32568831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
    Hartmann K; Hermes B; Rappersberger K; Sepp N; Mekori YA; Henz BM
    Br J Dermatol; 2003 Sep; 149(3):554-9. PubMed ID: 14510988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.
    Horny HP; Sotlar K; Valent P
    Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric mastocytosis.
    Hartmann K; Metcalfe DD
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):625-40. PubMed ID: 10909043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors.
    Matito A; Azaña JM; Torrelo A; Alvarez-Twose I
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):351-363. PubMed ID: 30007456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
    Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
    Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonality and molecular pathogenesis of mastocytosis.
    Akin C
    Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mastocytosis: from a Molecular Point of View.
    Komi DEA; Rambasek T; Wöhrl S
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mastocytosis.
    Tzankov A; Duncavage E; Craig FE; Kelemen K; King RL; Orazi A; Quintanilla-Martinez L; Reichard KK; Rimsza LM; Wang SA; Horny HP; George TI
    Am J Clin Pathol; 2021 Feb; 155(2):239-266. PubMed ID: 33313644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade.
    Gruchalla RS
    Am J Med Sci; 1995 Jun; 309(6):328-38. PubMed ID: 7771504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastocytosis: recent advances in defining the disease.
    Hartmann K; Henz BM
    Br J Dermatol; 2001 Apr; 144(4):682-95. PubMed ID: 11298525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.
    Casassa EA; Mailhol C; Tournier E; Laurent C; Degboe Y; Eischen M; Kirsten N; Moreau J; Evrard SM; Mansat-De Mas V; Lamant L; Dubreuil P; Apoil PA; Hermine O; Paul C; Bulai Livideanu C
    Allergol Int; 2019 Jan; 68(1):119-121. PubMed ID: 30097253
    [No Abstract]   [Full Text] [Related]  

  • 40. The skin in mastocytosis.
    Soter NA
    J Invest Dermatol; 1991 Mar; 96(3):32S-38S; discussion 38S-39S. PubMed ID: 1672136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.